Hydrogen sulfide ameliorates chronic renal failure in rats by inhibiting apoptosis and inflammation through ROS/MAPK and NF-κB signaling pathways
Chronic renal failure (CRF) is a major public health problem worldwide. Hydrogen sulfide (H 2 S) plays important roles in renal physiological and pathophysiological processes. However, whether H 2 S could protect against CRF in rats remains unclear. In this study, we found that H 2 S alleviated gent...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2017-03, Vol.7 (1), p.455-455, Article 455 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Chronic renal failure (CRF) is a major public health problem worldwide. Hydrogen sulfide (H
2
S) plays important roles in renal physiological and pathophysiological processes. However, whether H
2
S could protect against CRF in rats remains unclear. In this study, we found that H
2
S alleviated gentamicin-induced nephrotoxicity by reducing reactive oxygen species (ROS)-mediated apoptosis in normal rat kidney-52E cells. We demonstrated that H
2
S significantly improved the kidney structure and function of CRF rats. We found that H
2
S decreased the protein levels of Bax, Caspase-3, and Cleaved-caspase-3, but increased the expression of Bcl-2. Treatment with H
2
S reduced the levels of malondialdehyde and ROS and increased the activities of superoxide dismutase and glutathione peroxidase. H
2
S significantly abolished the phosphorylation of extracellular signal-regulated protein kinase 1/2, c-Jun N-terminal kinase, and p38 in the kidney of CRF rats. Furthermore, H
2
S decreased the expression levels of tumor necrosis factor-α, interleukin (IL)-6, IL-10, and monocyte chemoattractant protein-1, as well as the protein levels of p50, p65, and p-p65 in the kidney of CRF rats. In conclusion, H
2
S could ameliorate adenine-induced CRF in rats by inhibiting apoptosis and inflammation through ROS/mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-017-00557-2 |